Experiment summary for ENCSR000CYH

doi:10.17989/ENCSR000CYH

Summary

Status
released
Assay
transcription profiling by array assay (RNA microarray)
Biosample summary
Homo sapiens cardiac muscle cell originated from H7 treated with 5 ng/mL Fibroblast growth factor 2 for 14 days, 10 ng/mL Bone morphogenetic protein 4 for 14 days, 6 ng/mL Activin A for 14 days
Biosample Type
in vitro differentiated cells
Replication type
isogenic
Description
RNA Array on human H7-hESC differentiated for 14 days
Treatments
5 ng/mL Fibroblast growth factor 2 (UniProtKB:P09038) for 14 days, 10 ng/mL Bone morphogenetic protein 4 (UniProtKB:P12644) for 14 days, 6 ng/mL Activin A (CHEBI:81351) for 14 days
Nucleic acid type
RNA
Fragmentation methods
see document
Strand specificity
unstranded

Attribution

ENCODE2 project
Lab
John Stamatoyannopoulos, UW
Award
U54HG004592 (John Stamatoyannopoulos, UW)
Project
ENCODE
Date submitted
January 11, 2011
Date released
July 31, 2012
Treatment Time Series
ENCSR943VLP 

Isogenic replicates

Isogenic replicate
Technical replicate
Summary
Biosample
Library
21Homo sapiens female embryo cardiac muscle in vitro differentiated cells originated from H7 treated with 5 ng/mL Fibroblast growth factor 2 for 14 days, 10 ng/mL Bone morphogenetic protein 4 for 14 days, 6 ng/mL Activin A for 14 daysENCBS294AAAENCLB754URV
11Homo sapiens female embryo cardiac muscle in vitro differentiated cells originated from H7 treated with 5 ng/mL Fibroblast growth factor 2 for 14 days, 10 ng/mL Bone morphogenetic protein 4 for 14 days, 6 ng/mL Activin A for 14 daysENCBS294AAAENCLB736JNU